Skip to main content

Adenosine

NDC 68083-156 · Gland Pharma Limited

Generic nameAdenosine
Dosage formSOLUTION
RouteINTRAVENOUS
Active ingredient(s)ADENOSINE
Strength3 mg/mL
Pharmacologic classAdenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
Marketing categoryANDA

Packages

68083-156-10 — 10 VIAL in 1 CARTON (68083-156-10) / 2 mL in 1 VIAL

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51662-1632 — ADENOSINE, 51662-1643 — ADENOSINE, 55150-192 — Adenosine, 55150-193 — Adenosine, 63323-651 — Adenosine, 67457-854 — adenosine, 67457-855 — adenosine, 67457-856 — adenosine, 67457-857 — adenosine, 68083-101 — Adenosine, 68083-157 — Adenosine, 70518-4207 — Adenosine, 71217-0050 — niacinamide, adenosine, 71217-0060 — citronellol, geraniol, linalool, 71217-0061 — niacinamide, adenosine, 71288-207 — Adenosine, 71288-208 — Adenosine, 71872-7209 — adenosine, 71872-7335 — Adenosine, 72078-033 — adenosine, +80 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T46.2X1 — Poisoning by other antidysrhythmic drugs, accidental (unintentional), T46.2X2 — Poisoning by other antidysrhythmic drugs, intentional self-harm, T46.2X3 — Poisoning by other antidysrhythmic drugs, assault, T46.2X4 — Poisoning by other antidysrhythmic drugs, undetermined, T46.2X5 — Adverse effect of other antidysrhythmic drugs, T46.2X6 — Underdosing of other antidysrhythmic drugs